Survival and Risk Factors for Mortality in Infants With Congenital Heart Disease in South Korea

Jue Seong Lee1, Jeha Kwon2, Hannah Cho1

  • 1Department of Pediatrics, Korea University Medical Center, Korea University College of Medicine, Seoul, Republic of Korea.

PubMed

Insights

Infant survival with congenital heart disease (CHD) is high in South Korea, reaching 97.9%. Neonatal conditions like birth asphyxia significantly impact childhood mortality, highlighting the need for individualized risk assessment.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Neonatal Medicine

Background:

  • Congenital heart disease (CHD) survival has improved globally.
  • Disparities in CHD outcomes exist based on healthcare systems.
  • South Korea has a robust healthcare system for CHD management.

Purpose of the Study:

  • To analyze infant survival rates up to 18 years for congenital heart disease in South Korea.
  • To identify neonatal risk factors influencing childhood mortality in CHD patients.
  • To leverage large-scale population data for comprehensive analysis.

Main Methods:

  • Retrospective analysis of Korean National Health Insurance Service claims data (2002-2020).
  • Inclusion of infants diagnosed with CHD under one year of age.
  • Hierarchical classification of CHD lesions and identification of neonatal risk factors.

Main Results:

  • Overall childhood survival for infants with CHD was 97.9% (127,958 infants, 2,275 deaths).
  • Highest mortality rates were linked to non-conotruncal (19.7%) and conotruncal (10.2%) defects.
  • Significant mortality risk factors included complex CHD, pulmonary hypertension, birth asphyxia, and respiratory distress.

Conclusions:

  • Infant survival with CHD is favorable in South Korea.
  • Specific neonatal conditions are identified as critical risk factors for mortality.
  • Personalized risk assessment and treatment strategies are crucial for improving CHD survival.
Abstract